The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea

被引:54
|
作者
Tuori, A [1 ]
Virtanen, I [1 ]
Aine, E [1 ]
Uusitalo, H [1 ]
机构
[1] UNIV TAMPERE,SCH MED,DEPT OPHTHALMOL,FIN-33101 TAMPERE,FINLAND
关键词
D O I
10.1007/BF00941763
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: The etiology and pathogenesis of keratoconus remain unclear, and therefore we decided to study the distribution of different isoforms of tenascin (Tn) and fibronectin (Fn) in normal human corneas and in those obtained from penetrating keratoplasty for keratoconus and corneal scarring. Methods: Frozen sections of human cornea and conjunctiva were stained by immunohistochemical methods with a panel of monoclonal antibodies (MAbs) against different isoforms of Tn and Fn. Results: In the normal human eve, Tn was found in the limbal and conjunctival basement membrane region, in the conjunctival blood vessels and at the junction of the cornea and sclera, but no immunoreaction was seen in the normal cornea. In the corneas from the keratoconus patients, a clear immunoreaction for Tn was seen in the defects of Bowman's membrane as well as in the distorted stroma beneath the defects. In some of the keratoconus corneas, basement membrane adjacent to the defects also showed reactivity for Tn, and in clinically and histologically scarred keratoconus corneas the scars expressed Tn. In the scarred corneas, only blood vessels in the posterior portion of the cornea showed immunoreactivity for Tn, while no Tn was noted in the scar area or in Bowman's membrane. No major differences were noticed in the reactivity of different MAbs against Tn isoforms. Fn, extradomain A Fn (EDA-Fn) and oncofetal Fn (onc-Fn) were found in the basement membrane of the central cornea of the normal eye. In keratoconus corneas, the defects and clinical end histological scars bound MAbs against Fn, EDA-Fn and onc-Fn, but in the scarred corneas no enhancement in the expression of Fns was noted. Extradomain B cellular Fn (EDB-Fn) was not expressed in any of the eyes studied. Conclusions: The results suggest that the anterior portion of the cornea is involved in the pathogenesis of keratoconus. Furthermore, it seems that the expression of Tn and Fns in the clinically scarred keratoconus corneas is due to a process in which both repairing and scar-forming mechanisms operate at the same time. However, the origin of the defects in Bowman's membrane seen in keratoconus still remains unclear. They may be minor scars due to the disease or primary defects in the process leading to keratoconus.
引用
收藏
页码:222 / 229
页数:8
相关论文
共 50 条
  • [41] DISTRIBUTION OF SPECIFIC COLLAGEN TYPES AND FIBRONECTIN IN NORMAL AND KERATOCONUS CORNEAS
    TSUCHIYA, S
    TANAKA, M
    KONOMI, H
    HAYASHI, T
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 1986, 30 (01) : 14 - 31
  • [42] Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells
    Kinnula, VL
    Linnala, A
    Viitala, E
    Linnainmaa, K
    Virtanen, I
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 19 (03) : 445 - 452
  • [43] Gene expression profile studies of human keratoconus cornea for NEIBank: A novel cornea expressed gene and the absence of transcripts for aquaporin 5
    Dong, L
    Rabinowitz, YS
    Wistow, G
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [44] Metabolomic Signature Discriminates Normal Human Cornea from Keratoconus-A Pilot GC/MS Study
    Wojakowska, Anna
    Pietrowska, Monika
    Widlak, Piotr
    Dobrowolski, Dariusz
    Wylegala, Edward
    Tarnawska, Dorota
    MOLECULES, 2020, 25 (12):
  • [45] Tenascin-C variants in wound healing of the human cornea
    Maseruka, H
    Bonshek, RE
    Zardi, L
    Tullo, AB
    Ridgway, AEA
    VISION RESEARCH, 1996, 36 : 1326 - 1326
  • [46] Expression of transcription factors in keratoconus, a cornea-thinning disease
    Whitelock, RB
    Li, YH
    Zhou, LL
    Sugar, J
    Yue, BYJT
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (01) : 253 - 258
  • [47] Folding and stability of a fibronectin type III domain of human tenascin
    Clarke, J
    Hamill, SJ
    Johnson, CM
    JOURNAL OF MOLECULAR BIOLOGY, 1997, 270 (05) : 771 - 778
  • [48] EXPRESSION OF DIFFERENT TENASCIN ISOFORMS IN NORMAL, HYPERPLASTIC AND NEOPLASTIC HUMAN BREAST TISSUES
    BORSI, L
    CARNEMOLLA, B
    NICOLO, G
    SPINA, B
    TANARA, G
    ZARDI, L
    INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (05) : 688 - 692
  • [49] IMMUNOHISTOCHEMICAL EXPRESSION OF TENASCIN IN NORMAL HUMAN SALIVARY-GLANDS AND IN PLEOMORPHIC ADENOMAS
    SUNARDHIWIDYAPUTRA, S
    VANDAMME, B
    PATHOLOGY RESEARCH AND PRACTICE, 1993, 189 (02) : 138 - 143
  • [50] TENASCIN EXPRESSION IN HUMAN GLIOMA CELL-LINES AND NORMAL-TISSUES
    VENTIMIGLIA, JB
    WIKSTRAND, CJ
    OSTROWSKI, LE
    BOURDON, MA
    LIGHTNER, VA
    BIGNER, DD
    JOURNAL OF NEUROIMMUNOLOGY, 1992, 36 (01) : 41 - 55